NDC 0085-1264

Clarinex

Desloratadine

Clarinex is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Desloratadine.

Product ID0085-1264_22ffac95-2fe0-47f7-96c4-1d16f396cb5e
NDC0085-1264
Product TypeHuman Prescription Drug
Proprietary NameClarinex
Generic NameDesloratadine
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2001-12-21
Marketing CategoryNDA / NDA
Application NumberNDA021165
Labeler NameMerck Sharp & Dohme Corp.
Substance NameDESLORATADINE
Active Ingredient Strength5 mg/1
Pharm ClassesHistamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0085-1264-01

100 TABLET, FILM COATED in 1 BOTTLE (0085-1264-01)
Marketing Start Date2001-12-21
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0085-1264-03 [00085126403]

Clarinex TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA021165
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2001-12-21
Marketing End Date2013-07-22

NDC 0085-1264-04 [00085126404]

Clarinex TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA021165
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2001-12-21
Marketing End Date2013-07-22

NDC 0085-1264-01 [00085126401]

Clarinex TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA021165
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2001-12-21

NDC 0085-1264-02 [00085126402]

Clarinex TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA021165
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2001-12-21
Marketing End Date2015-11-30

Drug Details

Active Ingredients

IngredientStrength
DESLORATADINE5 mg/1

OpenFDA Data

SPL SET ID:5b79aff4-9bed-429d-8def-a7929293387d
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 755661
  • 352086
  • 607573
  • 349420
  • Pharmacological Class

    • Histamine H1 Receptor Antagonists [MoA]
    • Histamine-1 Receptor Antagonist [EPC]
    • Histamine H1 Receptor Antagonists [MoA]
    • Histamine-1 Receptor Antagonist [EPC]

    NDC Crossover Matching brand name "Clarinex" or generic name "Desloratadine"

    NDCBrand NameGeneric Name
    0085-1264ClarinexDesloratadine
    0085-1334ClarinexDesloratadine
    21695-815ClarinexDesloratadine
    50090-0765ClarinexDesloratadine
    78206-119ClarinexDesloratadine
    78206-188ClarinexDesloratadine
    0378-4017Desloratadinedesloratadine
    42291-240DesloratadineDesloratadine
    50090-3975DesloratadineDesloratadine
    50090-4794DESLORATADINEDESLORATADINE
    50268-218DesloratadineDesloratadine
    51672-4159DesloratadineDesloratadine
    55111-360DesloratadineDesloratadine
    55111-551DesloratadineDesloratadine
    62250-619DesloratadineDesloratadine
    62756-523DesloratadineDesloratadine
    63629-5270DesloratadineDesloratadine
    68180-153DESLORATADINEDESLORATADINE
    69543-107DesloratadineDesloratadine
    71335-1000DESLORATADINEDESLORATADINE

    Trademark Results [Clarinex]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    CLARINEX
    CLARINEX
    76160570 2595718 Dead/Cancelled
    SCHERING CORPORATION
    2000-11-06
    CLARINEX
    CLARINEX
    75464407 2455742 Live/Registered
    BAYER HEALTHCARE LLC
    1998-04-08

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.